Comparative efficacy and safety of local and systemic methotrexate injection in cesarean scar pregnancy
Open Access
- 1 January 2015
- journal article
- Published by Taylor & Francis Ltd in Therapeutics and Clinical Risk Management
- Vol. 11, 137-42
- https://doi.org/10.2147/TCRM.S76050
Abstract
Comparative efficacy and safety of local and systemic methotrexate injection in cesarean scar pregnancy Ping Peng,1 Ting Gui,1 Xinyan Liu,1 Weilin Chen,1 Zhenzhen Liu2 1Department of Obstetrics and Gynecology, 2Department of Ultrasonography, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China Objective: To investigate the efficacy of methotrexate (MTX) injection in treatment of cesarean scar pregnancy (CSP). Method: A randomized controlled study was performed in 104 CSP patients receiving either local or systemic MTX injection at the Peking Union Medical College Hospital from the year 2008 to 2013. Results: Complete cure was defined as regression of ultrasonographic findings and normalization of serum ß-hCG within 60 days. It was regarded as delayed cure if additional dilation and curettage (D&C) was needed. The overall cure rate (complete cure plus delayed cure) was 69.2% versus 67.3% for local injection versus systemic administration (P>0.05). The median time for serum β-hCG remission and uterine mass disappearance after systemic administration (42 [21–69] days and 40 [20–67] days) were significantly lower than those receiving local injection (56 [24–92] days and 53 [23–88] days), with P=0.029 and 0.046, respectively. The mean pretreatment serum β-hCG (human chorionic gonadotropin) level and lesion size in cured group (21,941±18,351 mIU/mL and 2.9±1.3 cm, respectively) were significantly lower than those in the failed group (37,047±30,864 mIU/mL and 3.6±1.3) with P=0.038 and 0.044, respectively. Conclusion: MTX injection is effective in CSP treatment. Systemic administration shows similar overall cure rate compared to local injection, but requires shorter time for serum β-hCG remission and uterine mass disappearance. Keywords: cesarean scar pregnancy, methotrexate injection, local, systemicKeywords
This publication has 16 references indexed in Scilit:
- Unforeseen consequences of the increasing rate of cesarean deliveries: early placenta accreta and cesarean scar pregnancy. A reviewAmerican Journal of Obstetrics and Gynecology, 2012
- The diagnosis, treatment, and follow-up of cesarean scar pregnancyAmerican Journal of Obstetrics and Gynecology, 2012
- Caesarean scar pregnancyCurrent Opinion in Obstetrics and Gynecology, 2011
- Transcatheter arterial chemoembolization versus systemic methotrexate for the management of cesarean scar pregnancyInternational Journal of Gynecology & Obstetrics, 2011
- Cesarean Scar Ectopic PregnanciesObstetrics & Gynecology, 2006
- First‐trimester diagnosis and management of pregnancies implanted into the lower uterine segment Cesarean section scarUltrasound in Obstetrics & Gynecology, 2003
- Cesarean scar pregnancyUltrasound in Obstetrics & Gynecology, 2003
- Implantation of a gestational sac in a cesarean section scarFertility and Sterility, 2001
- Successful methotrexate treatment of a viable pregnancy within a thin uterine scarBJOG: An International Journal of Obstetrics and Gynaecology, 1997
- An ectopic pregnancy developing in a previous caesarian section scarFertility and Sterility, 1997